Pilot study on sildenafil in labor withdrawn before starting
NCT ID NCT06377098
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 20 times
Summary
This study was designed to see if giving sildenafil (a blood pressure medicine) to women during labor could reduce complications like fetal distress and birth asphyxia in low-resource areas. It planned to enroll 0 participants and was withdrawn before any work began. The goal was to gather information for a larger future trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAPARTUM FETAL DISTRESS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cameroon Baptist Convention Health Services
Douala, Cameroon
-
Egerton University/Nakuru County Referral Hospital
Nakuru, Kenya
-
University Teaching Hospital
Lusaka, Zambia
Conditions
Explore the condition pages connected to this study.